Ocuphire Completes Enrollment of Over 100 Subjects in 24-Week ZETA-1 Phase 2b Trial of Oral APX3330 for the Treatment of Diabetic Retinopathy
Successful Execution and Completion of Enrollment in Four Late-Stage Clinical Trials Across Nyxol and APX3330…